Related Experiment Video
Updated: Aug 28, 2025

Human Circadian Phenotyping and Diurnal Performance Testing in the Real World
Published on: April 7, 2020
Excessive Daytime Sleepiness in Parkinson's Disease
Hanshu Liu1, Jingwen Li1, Xinyi Wang1
1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Excessive daytime sleepiness (EDS) is common in Parkinson's disease (PD). This review clarifies its prevalence, drug effects, and highlights neurodegeneration in wake-promoting nuclei as a key cause.
Area of Science:
- Neurology
- Sleep Medicine
- Neuroscience
Background:
- Excessive daytime sleepiness (EDS) is a prevalent and debilitating sleep disorder in Parkinson's disease (PD).
- It significantly impacts patient quality of life, increases accident risk, and presents diagnostic and therapeutic challenges.
- Understanding the underlying mechanisms and epidemiological variations of EDS in PD is crucial.
Purpose of the Study:
- To review the epidemiology of EDS in PD, addressing discrepancies between subjective and objective measures.
- To analyze the impact of antiparkinsonian drugs on EDS and elucidate their pharmacological mechanisms.
- To highlight the neurodegenerative basis of EDS in PD, focusing on wake-promoting nuclei and neurotransmitter systems.
Main Methods:
- Comprehensive literature review of studies on EDS in Parkinson's disease.
- Analysis of epidemiological data, including subjective and objective sleep measures.
- Examination of pharmacological effects of antiparkinsonian drugs on EDS.
Main Results:
- Inconsistent prevalence rates of EDS in PD are noted, influenced by measurement methods.
- Common antiparkinsonian drugs exhibit varied effects on EDS, necessitating careful clinical selection.
- Degeneration of wake-promoting nuclei is identified as a primary pathological mechanism for EDS in PD.
Conclusions:
- EDS in PD is multifactorial, influenced by disease progression and medication.
- Targeting neurodegenerative changes in wake-promoting pathways offers potential for novel EDS interventions in PD.
- Further research into sleep-wake cycle alterations is essential for developing effective treatments.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Narcolepsy
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...